Riskpilot← Back to searchSign inGet full accessLKH Läkarkonsult AB
ABActiveOrg 5569216178Solrosvägen 41Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2024
SEK 338K
-61% vs 2023
EBITDA margin
26.0%
+69% vs 2023
Equity ratio
86.3%
Financial strength
Net profit 2024
SEK 70K
+71% vs 2023
| Revenue | SEK 338K | -61% |
| EBITDA | SEK 88K | +69% |
| Net profit | SEK 70K | +71% |
| Total assets | SEK 277K | -14% |
| Equity | SEK 239K | +41% |
| Employees | 1 | — |
Legal name
LKH Läkarkonsult AB
Org number
5569216178
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
5 februari 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Aktiebolaget ska bedriva konsultverksamhet som utförs av legitimerad läkare med specialkompetens i psykiatri samt forskning och utbildning inom det medicinska området jämte därmed förenlig verksamhet.
Address
Solrosvägen 41
Email
lghlgh@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 480 | 988 | 1 345 | 866 | 338 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 256 | 113 | 276 | 52 | 88 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 256 | 113 | 276 | 52 | 88 |
| Net financials | — | — | — | — | — |
| Profit before tax | 256 | 122 | 276 | 52 | 88 |
| Tax | −55 | −25 | −57 | −11 | −18 |
| Net profit | 201 | 97 | 219 | 41 | 70 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 485 | 523 | 610 | 323 | 277 |
| Equity | 267 | 184 | 328 | 169 | 239 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 208 | 339 | 282 | 154 | 38 |
| Total debt | 208 | 339 | 282 | 154 | 38 |
EBITDA margin
26.0%
This company
15.8%
Market median
+65% vs market
20202024
Equity ratio
86.3%
This company
38.2%
Market median
+126% vs market
20202024
Return on equity
29.3%
This company
18.4%
Market median
+59% vs market
20202024
Net profit margin
20.7%
This company
8.1%
Market median
+156% vs market
20202024
Asset turnover
1.22×
This company
1.12×
Market median
+9% vs market
20202024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Board of Directors | 2020 | |
| Chairman | 2022 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LKH Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie-Louise Monica Margaretha Sethsson Halldén | Chairman | 0 companies |
| Lars-Göran Halldén | Deputy Board Member | 0 companies |
| André Magnus Nilén | Board of Directors | 0 companies |
| Lisa Karin Halldén | Chairman | 0 companies |